Bangladesh: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2025

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Bangladesh

The Bangladeshi market for other medicaments for therapeutic or prophylactic uses stood at $X in 2022, flattening at the previous year. In general, the total consumption indicated a temperate expansion from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. As a result, consumption attained the peak level of $X. From 2014 to 2022, the growth of the market failed to regain momentum.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Bangladesh

In value terms, production of other medicaments for therapeutic or prophylactic uses expanded modestly to $X in 2022 estimated in export price. In general, the total production indicated moderate growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by X% against 2020 indices. The pace of growth was the most pronounced in 2013 with an increase of X%. As a result, production attained the peak level of $X. From 2014 to 2022, production of growth failed to regain momentum.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Bangladesh

In 2022, after two years of growth, there was significant decline in shipments abroad of other medicaments for therapeutic or prophylactic uses, when their volume decreased by X% to X tons. In general, exports, however, enjoyed significant growth. The most prominent rate of growth was recorded in 2020 with an increase of X%. The exports peaked at X tons in 2021, and then dropped notably in the following year.

In value terms, exports of other medicaments for therapeutic or prophylactic uses plummeted to $X in 2022. Overall, exports, however, showed significant growth. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. As a result, the exports reached the peak of $X, and then contracted markedly in the following year.

Exports by Country

The UK (X tons), Namibia (X tons) and South Korea (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Bangladesh, together accounting for X% of total exports. Bolivia, Mongolia, Kenya and the Philippines lagged somewhat behind, together accounting for a further X%.

From 2012 to 2022, the biggest increases were recorded for Bolivia (with a CAGR of X.6%), while shipments for the other leaders experienced more modest paces of growth.

In value terms, the UK ($X) emerged as the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Bangladesh, comprising X% of total exports. The second position in the ranking was held by South Korea ($X), with a X% share of total exports. It was followed by Namibia, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the UK amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: South Korea (X% per year) and Namibia (X% per year).

Export Prices by Country

The average export price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, waning by X% against the previous year. In general, the export price recorded a abrupt decrease. The pace of growth appeared the most rapid in 2021 when the average export price increased by X% against the previous year. The export price peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to Mongolia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Namibia (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Bangladesh

In 2022, imports of other medicaments for therapeutic or prophylactic uses into Bangladesh shrank dramatically to X tons, reducing by X% against 2021 figures. In general, imports, however, enjoyed a strong expansion. The pace of growth appeared the most rapid in 2014 when imports increased by X% against the previous year. Over the period under review, imports of attained the maximum at X tons in 2021, and then fell dramatically in the following year.

In value terms, imports of other medicaments for therapeutic or prophylactic uses reduced notably to $X in 2022. Overall, imports, however, showed a strong increase. The pace of growth appeared the most rapid in 2014 with an increase of X% against the previous year. Over the period under review, imports of attained the peak figure at $X in 2021, and then dropped significantly in the following year.

Imports by Country

In 2022, the United States (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Bangladesh, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from the United States exceeded the figures recorded by the second-largest supplier, France (X tons), threefold. China (X tons) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from the United States totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: France (X% per year) and China (X% per year).

In value terms, India ($X), China ($X) and the United States ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to Bangladesh, with a combined X% share of total imports.

China, with a CAGR of X%, saw the highest rates of growth with regard to the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, growing by X% against the previous year. In general, the import price recorded a relatively flat trend pattern. The pace of growth appeared the most rapid in 2013 when the average import price increased by X%. As a result, import price attained the peak level of $X per ton. From 2014 to 2022, the average import prices remained at a lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Switzerland ($X per ton), while the price for the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by India (X%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :